Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
2 registered trials, newest registry update first. Showing only trials linked to Apitegromab.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese NCT06445075 | Apitegromab | Phase 2 | Completed | Scholar Rock, Inc. | 102 | Mar 4, 2025 | Jan 23, 2026 |
| Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam NCT05156320 | Apitegromab | Phase 3 | Completed | Scholar Rock, Inc. | 188 | Dec 18, 2024 | Jan 22, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.